Clinical Trial: Efficacy and Safety of Intravenous Meloxicam in Subjects With Moderate-to-severe Pain Following Abdominal Surgery

U.S., April 2 -- ClinicalTrials.gov registry received information related to the study (NCT06904248) titled 'Efficacy and Safety of Intravenous Meloxicam in Subjects With Moderate-to-severe Pain Following Abdominal Surgery' on March 25.

Brief Summary: This study aims to evaluate the analgesic efficacy and safety of meloxicam injection in subjects with moderate-to-severe pain following abdominal surgery. The primary efficacy endpoint is the summed pain intensity difference over 24 hours ( SPID24)

Study Start Date: Jan. 29, 2024

Study Type: INTERVENTIONAL

Condition: Participants With Acute Moderate to Severe Pain Following Abdominal Surgery

Intervention: DRUG: Meloxicam Injection

Intravenous meloxicam Injection, 30mg every 24 hours, f...